Before 2024

Starting Point

Initiate the exploration of the application value of neuromodulation technology. Lay the foundation for the subsequent development of products.

2025 Q1

Establishment

Focusing on the research and application of neural regulation technology, deeply cultivating medical innovation, will bring more innovative medical solutions to patients.

2025 Q3

Evaluation Preparation

Complete product design and initial research and development, and advance the preparation work for clinical evaluation. Ensure the safety and effectiveness of the product, and steadily promote the implementation of the project.

2025 Q4

Registration

Complete the entire regulatory approval process, obtain the medical device registration certificate, and assist in the official launch of the product

From 2026

Official Launch

Yikong sticker ™ Formally launched on the market, empowering patients with improved quality of life through innovative neural regulation therapies (effectively improving patients quality of life).

From 2026

Further Expansion

Based on the success of EaseFlow™ Patch, we will continue to expand our product line, developing more innovative medical technologies to serve more patients.

Future

Stay Tuned----

Continuously expanding the product matrix, iterating innovative medical technologies, providing more breakthrough medical solutions for patients worldwide, and benefiting more patients.

EaseFlow™ Patch

EaseFlow™ Patch